Eml
Advertising Networks · Colombia · 51-200 Employees
View Company Info for Free
Overview
Headquarters
# 103b 32 Carrera 46, Cundinamarca, 1111...Website
www.eml.coRevenue
$14 MillionIndustry
About Eml
Eml Org Chart
Is Eml your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Eml had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Eml is spiking on competitors!
Funding: Get notified immidiatlly once Eml has new funding data
Earning: See what the market has to say on Eml recently announced quarterly report
Eml, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Eml has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Eml
Product Launch: Get notified when Eml launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Eml is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Eml is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Eml.
Eml Tech Stack
A closer look at the technologies used by Eml
Top Advertising Networks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Eml
EML is a specialized agency focused on experiential marketing and 360 campaigns for the healthcare sector. They offer a range of services including strategic communications, digital marketing, and immersive interactive technologies. Their clients include major pharmaceutical and healthcare brands such as Bristol Myers Squibb, Astrazeneca, and Novar... Read More